diabetes mellitus type II
Showing 9976 - 10000 of >10,000
Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)
Not yet recruiting
- Follicular Lymphoma
- Low Grade Non-Hodgkin's Lymphoma, Adult
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 13, 2023
Headache Trial in Roma (Myofascial Release (MR), clinical practice drug treatment, Manual therapy (MT))
Recruiting
- Headache
- Myofascial Release (MR)
- +3 more
-
Roma, RM, ItalyRehabilitation Department Fondazione Policlinico Universitario C
Aug 10, 2023
Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)
Not yet recruiting
- Solid Tumor, Adult
- HB0045 Drug Product
-
Boston, Massachusetts
- +2 more
Sep 20, 2023
Renal Disease Trial in United States (APOL1 status)
Recruiting
- Renal Disease
- APOL1 status
-
Birmingham, Alabama
- +13 more
Dec 16, 2022
NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- efineptakin alfa
- Atezolizumab
-
Mobile, Alabama
- +14 more
May 12, 2022
FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer
Completed
- FIGO Stage III and IV Ovarian Cancer
- +2 more
- ALT-803 Subcutaneous
- ALT-803 Intraperitoneal
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Oct 5, 2022
Migraine, Tension-Type Headache, Neck Pain Trial in Glostrup (strength training)
Active, not recruiting
- Migraine
- +2 more
- strength training
-
Glostrup, DenmarkDanish Headache Center Rigshospitalet - Glostrup
Oct 27, 2023
Pre-diabetes Trial in New York (Fixed Schedule)
Recruiting
- Pre-diabetes
- Fixed Schedule
-
New York, New YorkColumbia University Irving Medical Center
Sep 6, 2022
Symptomatic Irreversible Pulpitis Trial in Indianapolis (Onset Sodium Bicarbonate Inj., 8.4%, USP Neutralizing Additive
Recruiting
- Symptomatic Irreversible Pulpitis
- Onset Sodium Bicarbonate Inj., 8.4%, USP Neutralizing Additive Solution
- 2% lidocaine with 1:100,000 epinephrine
-
Indianapolis, IndianaIndiana University School of Dentistry Graduate Endodontics Dept
Mar 28, 2022
HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))
Completed
- HIV Infections
- DTG + 3TC
- TAF based regimen (TBR)
-
Phoenix, Arizona
- +132 more
Jun 27, 2022
Headache Trial in Ankara (Cervical stabilization exercises)
Completed
- Headache
- Cervical stabilization exercises
-
Ankara, TurkeyGazi University
Apr 20, 2023
Diabetic Gastroparesis Trial in United States (CGMS and insulin pump)
Completed
- Diabetic Gastroparesis
- CGMS and insulin pump
-
San Francisco, California
- +6 more
Feb 7, 2022
Coronavirus Infection, COVID-19 Trial in Saint Petersburg (Low dose BCD-250 injection, High dose BCD-250 injection, Low dose or
Recruiting
- Coronavirus Infection
- COVID-19
- Low dose BCD-250 injection
- +3 more
-
Saint Petersburg, Russian Federation
- +1 more
Sep 7, 2021
Merkel Cell Carcinoma Trial in Australia (Carboplatin, Etoposide, Radiotherapy)
Completed
- Merkel Cell Carcinoma
- Carboplatin
- +2 more
-
Campbelltown, New South Wales, Australia
- +12 more
Nov 17, 2022
Colorectal Cancer, Liver Metastases Trial (QBECO, Placebo)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- QBECO
- Placebo
- (no location specified)
Jan 6, 2023
Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))
Recruiting
- Malignant Sarcoma
- Natural Killer (NK) cells (a new immunotherapy)
-
Madrid, SpainHospital Universitario La Paz
Jul 19, 2023
Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,
Completed
- Acute Myeloid Leukemia
- +2 more
- Decitabine
- +2 more
-
Minneapolis, Minnesota
- +2 more
Nov 2, 2022
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Recruiting
- Acute Lymphoblastic Leukemia
- Large B-cell Lymphoma
- KYMRIAH
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston
Recruiting
- Heart Failure With Normal Ejection Fraction
- +3 more
- 11C-Martinostat
- PET-MRI
-
Boston, MassachusettsMassachusetts General Hospital
Mar 1, 2022
Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Diabetes Trial (Educational intervention)
Not yet recruiting
- Schizophrenia
- +6 more
- Educational intervention
- (no location specified)
Jul 10, 2023
Cardiovascular Diseases Trial in New York (Empagliflozin, Placebos)
Completed
- Cardiovascular Diseases
- Empagliflozin
- Placebos
-
New York, New YorkMount Sinai Heart - Icahn School of Medicine at Mount Sinai
Mar 2, 2021
Advanced Malignant Tumors Trial in Shanghai (AK104, AK117, Capecitabine tablets)
Recruiting
- Advanced Malignant Tumors
- AK104
- +8 more
-
Shanghai, ChinaShanghai Renji Hospital
Aug 9, 2022
Pulmonary Function and CT Scan Finding in CKD Patients After
Recruiting
- COVID-19
- +2 more
- Pulmonary function test
- Chest computer scan
-
Bangkok, ThailandFaculty of Medicine ,Vajira hospital,Navamindradhiraj University
Jul 18, 2022